| DC Field | Value | Language |
|---|
| dc.contributor.author | Safronenko, A. V. | - |
| dc.contributor.author | Lepyavka, S. V. | - |
| dc.contributor.author | Demidov, I. A. | - |
| dc.contributor.author | Nazheva, M. I. | - |
| dc.contributor.author | Maklyakov, Y. S. | - |
| dc.date.accessioned | 2022-05-11T12:57:56Z | - |
| dc.date.available | 2022-05-11T12:57:56Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Optimization of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances with Amiodarone-associated thyrotoxicosis / A.V. Safronenko [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №4.-P. 55-62. - Doi: 10.3897/rrpharmacology.7.78137. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46664 | - |
| dc.description.abstract | The effectiveness of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances against the background of Amiodarone-associated thyrotoxicosis, high anxiety and cyclothymiae disorders should be based on the pharmacological positions of the need to reduce the risk of dangerous adverse cardiovascular reactions | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | amiodarone | ru |
| dc.subject | arrhythmia | ru |
| dc.subject | arterial hypertension | ru |
| dc.subject | benzodiazepines | ru |
| dc.subject | thyrotoxicosis | ru |
| dc.subject | side effects | ru |
| dc.subject | premedication | ru |
| dc.title | Optimization of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances with Amiodarone-associated thyrotoxicosis | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 4
|
